3BRAITEH F, KURZROCK R, JOHNSON FM. Trichomega- ly of the eyelashes after lung cancer treatment with the epi- dermal growth factor receptor inhibitor erlotinib[J]. J Clin Oncol, 2008, 26(20):3460-3462.
4FINLAY AY, KHAN GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use [J]. Clin Exp Dermatol, 1994,19(3) :210-216.
5YOSHIKA H, HOTYA K, KIURA K, et al. A phase Ⅲ trial of erlotinib mono therapy in pretreated patients with ad- vanced NSCLC who do not possess active EGFR mutations Okayama Lung Cancer Study Group trial 0705[J].J Thorac Oncol,2010,5(1) :99-104.
6中国药典[S].一部.2015.
7谢彬彬.葛根素单克隆抗体免疫亲和色谱柱的制备[D],北京:北京中医药大学,2012.
8Zheng Q Y,Ye M.Chemical analysis of Chinese herbal medicine Gan-ao (licorice)[J].J Chromatogr A,2009,1216(11):1954-1969.
9Farag M A,Porzel A,Wessjohann L A.Comparative metabolite profiling and fingerprinting of medicinal licorice roots using a multiplex approach of GC-MS,LC-MS and ID NMR techniques [J].Phytochemistry,2012,76:60-72.
10Rackova L.Mechanisn of anti-inflanmamry action of liquorice extract and glycyrrhizin [J].Nat Prod Res,2007,21(14):1234-1241.
